Metabolic syndrome and aging: Calcium signaling as common regulator

Current Diabetes Reviews

Volumn 12, Issue 2, 2016, Pages 84-89

  Soprano, Maria ^a   Rusciano, Maria Rosaria ^a   Ciccarelli, Michele ^b   Maione, Angela Serena ^a   Formisano, Pietro ^a   Illario, Maddalena ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Aging; Calcium signaling; Frailty; Metabolic syndrome

Indexed keywords

CALCIUM; INSULIN;

AGING; ARTICLE; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; FRAIL ELDERLY; HUMAN; INSULIN RESISTANCE; LIFE EXPECTANCY; METABOLIC DISORDER; METABOLIC SYNDROME X; MOLECULAR MECHANICS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SOCIETY; AGED; PATHOPHYSIOLOGY;

AGED; AGING; CALCIUM SIGNALING; HUMANS; LIFE EXPECTANCY; METABOLIC SYNDROME X; RISK FACTORS;

EID: 84959377287     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/1573399811666150722124701     Document Type: Article

References (69)

1. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: 943162.
2. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab 2007; 32: 23-32.
3. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436.
4. Holliday R. Chance and longevity. Bioessays 1995; 17: 465-467.
5. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and agerelated diseases. Biogerontology 2010; 11: 547-563.
6. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-156.
7. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004,59: 255-263.
8. Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med 2006; 166: 418-423.
9. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341.
10. Barzilay JI, Blaum C, Moore T, et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007; 167: 635-641.
11. Carcaillon L, Blanco C, Alonso-Bouzon C, Alfaro-Acha A, Garcia- Garcia FJ, Rodriguez-Manas L. Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One 2012; 7: e32401.
12. Carcaillon L, Garcia-Garcia FJ, Tresguerres JA, Gutierrez Avila G, Kireev R, Rodriguez-Manas L. Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the toledo study for healthy aging. J Clin Endocrinol Metab 2012; 97: 2898-2906.
13. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56: M158-166.
14. Fedarko NS. The biology of aging and frailty. Clin Geriatr Med 2011; 27: 27-37.
15. Klein BE, Klein R, Knudtson MD, Lee KE. Frailty, morbidity and survival. Arch Gerontol Geriatr 2005; 41: 141-149.
16. Saltevo J, Niskanen L, Kautiainen H, et al. Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol 2011; 165: 429-434.
17. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 2005; 54: 3336-3339.
18. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119: S10-16.
19. Borge PD, Moibi J, Greene SR, et al. Insulin receptor signaling and sarco/endoplasmic reticulum calcium ATPase in beta-cells. Diabetes 2002; 51 Suppl 3: S427-433.
20. Hodgkin MN, Hills CE, Squires PE. The calcium-sensing receptor and insulin secretion: a role outside systemic control 15 years on. J Endocrinol 2008; 199: 1-4.
21. Chin ER. The role of calcium and calcium/calmodulin-dependent kinases in skeletal muscle plasticity and mitochondrial biogenesis. Proc Nutr Soc 2004; 63: 279-286.
22. Illario M, Monaco S, Cavallo AL, et al. Calcium-calmodulindependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cell Signal 2009; 21: 786-792.
23. Ojuka EO, Goyaram V, Smith JA. The role of CaMKII in regulating GLUT4 expression in skeletal muscle. Am J Physiol Endocrinol Metab 2012; 303: E322-331.
24. Brozinick JT, Jr., Reynolds TH, Dean D, Cartee G, Cushman SW. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxiastimulated glucose transport in skeletal muscle. Biochem J 1999; 339 (Pt 3): 533-540.
25. Wright DC, Fick CA, Olesen JB, Lim K, Barnes BR, Craig BW. A role for calcium/calmodulin kinase in insulin stimulated glucose transport. Life Sci 2004; 74: 815-825.
26. Funai K, Song H, Yin L, et al. Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling. J Clin Invest 2013; 123: 1229-1240.
27. Miles JM, Jensen MD. Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 2005; 28: 2326-2328.
28. Ozcan L, Wong CC, Li G, et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 2012; 15: 739-751.
29. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990; 11 Suppl E: 3-19.
30. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005; 96: 930-938.
31. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260: 192-210.
32. Vickers KC, Castro-Chavez F, Morrisett JD. Lysophosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells. Atherosclerosis 2010; 211: 122-129.
33. Redgrave JN, Lovett JK, Rothwell PM. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke 2010; 41: 2288-2294.
34. Goel M, Wong ND, Eisenberg H, Hagar J, Kelly K, Tobis JM. Risk factor correlates of coronary calcium as evaluated by ultrafast computed tomography. Am J Cardiol 1992; 70: 977-980.
35. Janowitz WR, Agatston AS, Kaplan G, Viamonte M, Jr. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993; 72: 247-254.
36. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-354.
37. Fox CS, Hwang SJ, Massaro JM, et al. Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Am J Cardiol 2009; 104: 543-547.
38. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
39. Allison MA, Michael Wright C. Body morphology differentially predicts coronary calcium. Int J Obes Relat Metab Disord 2004; 28: 396-401.
40. Cassidy AE, Bielak LF, Zhou Y, et al. Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation 2005; 111: 1877-1882.
41. Lee CD, Jacobs DR, Jr., Schreiner PJ, Iribarren C, Hankinson A. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 2007; 86: 48-54.
42. Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol 1996; 27: 277-284.
43. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000; 86: 495-498.
44. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19- month follow-up of 1173 asymptomatic subjects. Circulation 1996; 93: 1951-1953.
45. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-1345.
46. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
47. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658-1667.
48. Ureshino RP, Rocha KK, Lopes GS, Bincoletto C, Smaili SS. Calcium signaling alterations, oxidative stress, and autophagy in aging. Antioxid Redox Signal 2014; 21: 123-137.
49. Squier TC. Oxidative stress and protein aggregation during biological aging. Exp Gerontol 2001; 36: 1539-1550.
50. Ermak G, Davies KJ. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002; 38: 713-721.
51. de Souza L, Smaili SS, Ureshino RP, et al. Effect of chronic sleep restriction and aging on calcium signaling and apoptosis in the hippocampus of young and aged animals. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 23-30.
52. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2000; 23: 222-229.
53. Georgeon-Chartier C, Menguy C, Prevot A, Morel JL. Effect of aging on calcium signaling in C57Bl6J mouse cerebral arteries. Pflugers Arch 2013; 465: 829-838.
54. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-294.
55. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-223.
56. Gumbiner B, Thorburn AW, Ditzler TM, Bulacan F, Henry RR. Role of impaired intracellular glucose metabolism in the insulin resistance of aging. Metabolism 1992; 41: 1115-1121.
57. Goulet ED, Hassaine A, Dionne IJ, et al. Frailty in the elderly is associated with insulin resistance of glucose metabolism in the postabsorptive state only in the presence of increased abdominal fat. Exp Gerontol 2009; 44: 740-744.
58. Elahi D, Muller DC, McAloon-Dyke M, Tobin JD, Andres R. The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol 1993; 28: 393-409.
59. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006; 61: 262-266.
60. Boyd CM, Xue QL, Simpson CF, Guralnik JM, Fried LP. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med 2005; 118: 1225-1231.
61. Wolinsky FD, Callahan CM, Fitzgerald JF, Johnson RJ. Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol 1993; 48: S94-101.
62. Blaum CS, Xue QL, Tian J, Semba RD, Fried LP, Walston J. Is hyperglycemia associated with frailty status in older women? J Am Geriatr Soc 2009; 57: 840-847.
63. Kalyani RR, Varadhan R, Weiss CO, Fried LP, Cappola AR. Frailty status and altered glucose-insulin dynamics. J Gerontol A Biol Sci Med Sci 2012; 67: 1300-1306.
64. Serra-Prat M, Palomera E, Clave P, Puig-Domingo M. Effect of age and frailty on ghrelin and cholecystokinin responses to a meal test. Am J Clin Nutr 2009; 89: 1410-1417.
65. Cipolletta E, Monaco S, Maione AS, et al. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology 2010; 151: 2747-2759.
66. Jones RJ, Jourd'heuil D, Salerno JC, Smith SM, Singer HA. iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2007; 292: H2634-2642.
67. Weiss CO, Hoenig HH, Varadhan R, Simonsick EM, Fried LP. Relationships of cardiac, pulmonary, and muscle reserves and frailty to exercise capacity in older women. J Gerontol A Biol Sci Med Sci 2010; 65: 287-294.
68. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009; 103: 1616-1621.
69. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014; 63: 747-762.